Beneficial Impact of Fenoldopam in Critically Ill Patients With or at Risk for Acute Renal Failure: A Meta-Analysis of Randomized Clinical Trials
Authors:
- Giovanni LandoniGLGiovanni Landoni
- Giuseppe G.L. Biondi-ZoccaiGiuseppe G.L. Biondi-Zoccai
- James A. TumlinJTJames A. Tumlin
- Tiziana BoveTBTiziana Bove
- Monica De LucaMLMonica De Luca
- Maria Grazia CalabròMCMaria Grazia Calabrò
- Marco RanucciMarco Ranucci
- Alberto ZangrilloAZAlberto Zangrillo
- 1 January 2007
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 49 (1) , 56-68
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients*Critical Care Medicine, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopamThe American Journal of Cardiology, 2002
- EFFECTS OF FENOLDOPAM, A DOPAMINE D-1 AGONIST, AND CLEVIDIPINE, A CALCIUM CHANNEL ANTAGONIST, IN ACUTE RENAL FAILURE IN ANESTHETIZED RATSClinical and Experimental Hypertension, 2002
- Differential Human Renal Tubular Responses to Dopamine Type 1 Receptor Stimulation Are Determined by Blood Pressure StatusHypertension, 1997
- Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure modelsKidney International, 1994
- Fenoldopam infusion for the treatment of postoperative hypertensionJournal of Clinical Anesthesia, 1993
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993
- Intravenous fenoldopam in heart failure: Comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprussideAmerican Heart Journal, 1988
- Hemodynamic effects of an oral dopamine receptor agonist (fenoldopam) in patients with congestive heart failureJACC, 1985